Lytix Biopharma Balance Sheet Health
Financial Health criteria checks 6/6
Lytix Biopharma has a total shareholder equity of NOK51.4M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK63.4M and NOK12.1M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr50.55m |
| Equity | kr51.37m |
| Total liabilities | kr12.06m |
| Total assets | kr63.44m |
Recent financial health updates
We're A Little Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Mar 02
We're Keeping An Eye On Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Oct 04We Think Lytix Biopharma (OB:LYTIX) Can Afford To Drive Business Growth
Jun 21Companies Like Lytix Biopharma (OB:LYTIX) Are In A Position To Invest In Growth
Jan 11We're Not Very Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Jul 16We're Not Very Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Jan 25Recent updates
We're A Little Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Mar 02We're Keeping An Eye On Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Oct 04We Think Lytix Biopharma (OB:LYTIX) Can Afford To Drive Business Growth
Jun 21Companies Like Lytix Biopharma (OB:LYTIX) Are In A Position To Invest In Growth
Jan 11We're Not Very Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Jul 16We're Not Very Worried About Lytix Biopharma's (OB:LYTIX) Cash Burn Rate
Jan 25We Think Lytix Biopharma (OB:LYTIX) Can Afford To Drive Business Growth
Sep 14Financial Position Analysis
Short Term Liabilities: LYTIX's short term assets (NOK63.3M) exceed its short term liabilities (NOK12.1M).
Long Term Liabilities: LYTIX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: LYTIX is debt free.
Reducing Debt: LYTIX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LYTIX has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: LYTIX is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.